Efficacy and safety of peginterferon alfa-2a + ribavirin +/- raloxifene in the treatment of chronic genotype 1b hepatitis C in postmenopausal women.
Phase of Trial: Phase II
Latest Information Update: 11 May 2012
At a glance
- Drugs Raloxifene (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 May 2012 New trial record